These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38856749)

  • 1. Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate Cancer.
    Heath EI; Thakur A; Chen W; Hwang C; Paller CJ; Cackowski FC; Boerner JL; Heilbrun L; Smith MP; Schalk DL; Schienschang A; Whitaker SA; Polend A; Smith D; Vaishampayan UN; Dickow B; Lum LG
    Cancer Res Commun; 2024 Jul; 4(7):1715-1725. PubMed ID: 38856749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [
    Muniz M; Sartor O; Orme JJ; Koch RM; Rosenow HR; Mahmoud AM; Andrews JR; Kase AM; Riaz IB; Belge Bilgin G; Thorpe MP; Kendi AT; Johnson GB; Ravi P; Kwon ED; Childs DS
    J Nucl Med; 2024 Dec; 65(12):1932-1938. PubMed ID: 39477495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T.
    Brown MC; D'Anniballe VM; Boczkowski D; Kandadi H; Sheikh N; Kornahrens W; Heath EI; Thakur A; Chen W; Lum L; Cackowski FC; Boerner J; Gunn MD; Armstrong AJ; Nair SK
    Cancer Res Commun; 2024 Oct; 4(10):2724-2733. PubMed ID: 39320053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients.
    Kleiburg F; de Geus-Oei LF; Luelmo SAC; Spijkerman R; Goeman JJ; Toonen FAJ; Smit F; van der Hulle T; Heijmen L
    Eur J Radiol; 2024 Dec; 181():111774. PubMed ID: 39442347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu-PSMA Therapy.
    Jafari E; Manafi-Farid R; Ahmadzadehfar H; Salek F; Jokar N; Keshavarz A; Divband G; Dadgar H; Zohrabi F; Assadi M
    Nuklearmedizin; 2024 Dec; 63(6):347-358. PubMed ID: 39227023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
    Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S
    Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Dendritic Cells Isolated from the Blood of Patients with Prostate Cancer by Ex Vivo Fluid Shear Stress Stimulation.
    Dombroski JA; Antunovic M; Schaffer KR; Hurley PJ; King MR
    Curr Protoc; 2023 Dec; 3(12):e933. PubMed ID: 38047658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the Trends in Racial Diversity Among Orthopaedic Applicants, Residents, and Faculty?
    Kalyanasundaram G; Mener A; DiCaprio MR
    Clin Orthop Relat Res; 2023 Dec; 481(12):2354-2364. PubMed ID: 37220184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of White and African American groups reveals unique lipid and inflammatory features of diabetes.
    Pacheco Sanchez G; Lopez M; Velez LM; Tamburini I; Ujagar N; Ayala J; Robles G; Choi H; Arriola J; Kapadia R; Zonderman AB; Evans MK; Jang C; Seldin MM; Nicholas DA
    medRxiv; 2024 Nov; ():. PubMed ID: 39606357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving
    Demirci RA; Gulati R; Hawley JE; Yezefski T; Haffner MC; Cheng HH; Montgomery RB; Schweizer MT; Yu EY; Nelson PS; Chen DL; Iravani A
    J Nucl Med; 2024 Dec; 65(12):1945-1951. PubMed ID: 39510589
    [No Abstract]   [Full Text] [Related]  

  • 16. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of rechallenge with [
    Santo G; Di Santo G; Sviridenko A; Bayerschmidt S; Wirth L; Scherbauer F; Lehmann P; von Guggenberg E; Decristoforo C; Heidegger-Pircher I; Bektic J; Virgolini I
    Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):354-365. PubMed ID: 39225826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Posttherapy 4- and 24-Hour [
    Swiha M; Pathmanandavel S; Papa N; Sabahi Z; Li S; Zheng A; Khan S; Ayers M; Sharma S; Crumbaker M; Nguyen A; Chan L; Ayati N; Emmett L
    J Nucl Med; 2024 Dec; 65(12):1939-1944. PubMed ID: 39477497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.